FTase-IN-1
Modify Date: 2024-01-09 23:26:07
FTase-IN-1 structure
|
Common Name | FTase-IN-1 | ||
|---|---|---|---|---|
| CAS Number | 2490538-41-3 | Molecular Weight | 384.45 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C23H16N2O2S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of FTase-IN-1FTase-IN-1 (compound 17a) is a potent and specific inhibitor of fanesyl transferase (FTase) with an IC50 of 0.35 μM. FTase-IN-1 displays cytotoxicity potential and antitumor activity[1]. |
| Name | FTase-IN-1 |
|---|
| Description | FTase-IN-1 (compound 17a) is a potent and specific inhibitor of fanesyl transferase (FTase) with an IC50 of 0.35 μM. FTase-IN-1 displays cytotoxicity potential and antitumor activity[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 0.35 μM (fanesyl transferase)[1] |
| In Vitro | FTase-IN-1 (compound 17a) (10 μM, 48 h) is an inhibitors of farnesyl transferase (FTase) and inhibits NCI-60 cells proliferation in vitro[1]. FTase-IN-1 (10 μM, 48 h) arrests the cell growth of multiple cancer cell lines with GI50 range from 1.8 to 6.5 nM[1]. Cell Viability Assay[1] Cell Line: NCI-H522 (lung cancer), COLO-205 and HT29 (colon cancer), SF-539 (human glioblastoma), MDA-MB-435 (melanoma), OVCAR-3 (ovarian cancer) and A498 (renal cancer) Concentration: 10 μM Incubation Time: 48 hours Result: Inhibited cell growth and showed strong antitumor activity. |
| References |
| Molecular Formula | C23H16N2O2S |
|---|---|
| Molecular Weight | 384.45 |